372481008: Skin anti-infective (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1197774010 Skin anti-infective (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1211016014 Skin anti-infective en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

189931000077110 anti-infectieux cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
anti-infectieux cutané	Is a	Local anti-infective	false	Inferred relationship	Some
anti-infectieux cutané	Is a	Anti-infective agent (substance)	false	Inferred relationship	Some
anti-infectieux cutané	Is a	agent cutané	false	Inferred relationship	Some
anti-infectieux cutané	Is a	agent topique cutané	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/3.5mg/10000 unit suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/1000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Hydrocortisone + polymyxin b 5mg/10000unt drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Polymyxin b sulfate + trimethoprim sulfate 10000unt/1mg ophthalmic solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Neo-tabs 500mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Mycifradin 125mg/5mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Neo-fradin 125mg/5mL oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Polymyxin b sulfate + trimethoprim sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Colistin sulfate + hydrocortisone acetate + neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Hydrocortisone acetate+neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
médicament contenant dexaméthasone et néomycine et polymyxine B	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Cetylpyridinium chloride+ ascorbic acid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing dexamethasone sodium phosphate and neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Bacitracin zinc + polymyxin b sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely neomycin sulfate 5 milligram/1 milliliter and prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Clobetasol propionate+neomycin sulfate+Nystatin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Medicinal product containing cyclic lipopeptide and acting as antibacterial agent (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing daptomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Neomycin 0.5% ear drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Daptomycin 250mg injection solution 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Daptomycin 500mg injection solution 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing lidocaine and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Betamethasone+neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Chlorhexidine hydrochloride+neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing clobetasone butyrate and neomycin sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Iodophore (substance)	Is a	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing chlorocresol and potassium hydroxyquinoline sulfate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Chlorocresol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing cetylpyridinium and lidocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing betamethasone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing methylprednisolone and neomycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing neomycin and triamcinolone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing polymyxin B and trimethoprim (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing bacitracin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing cetylpyridinium and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Product containing cetylpyridinium and menthol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	anti-infectieux cutané	Inferred relationship	Some
Mercuric oxide	Is a	False	anti-infectieux cutané	Inferred relationship	Some
Carbol-fuchsin topical solution	Is a	False	anti-infectieux cutané	Inferred relationship	Some
Halquinol	Is a	False	anti-infectieux cutané	Inferred relationship	Some
Undecoylium chloride iodine (substance)	Is a	False	anti-infectieux cutané	Inferred relationship	Some
Sodium meralein	Is a	False	anti-infectieux cutané	Inferred relationship	Some
Local anti-infective and anti-inflammatory poisoning	Causative agent (attribute)	False	anti-infectieux cutané	Inferred relationship	Some
Poisoning caused by local anti-infective	Causative agent (attribute)	False	anti-infectieux cutané	Inferred relationship	Some

Start Page 2 of 2

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1197774010	Skin anti-infective (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211016014	Skin anti-infective	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
189931000077110	anti-infectieux cutané	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module